Merel Boers

Cofounder and Chief research officer at Nico.lab

"I have been working with NLC for a couple of years. From the first moment, NLC saw opportunities where I didn’t. Without the expertise and commitment of NLC, Nico.lab simply wouldn’t exist and we wouldn’t be able to help stroke patients this day"

Alex Vernooij

PDEng, CTO at Concord Neonatal

"NLC has been excited from the very first moment we talked about our invention: the Concord Birth Trolley. But they also challenged us with questions that were new to us. Above all, NLC has matched us to a passionate entrepreneur. Without NLC, we wouldn't be able to improve birth for vulnerable babies as we are today."

Prof. Dr. Keita Ito

Inventor, origin: TU/e

"NC Biomatrix has developed the first regenerative technology for spinal disc nuclei, using an injectable biomatrix, for the treatment of intervertebral disc degeneration (IVD). This can be done in an outpatient setting, avoiding the risks and costs of surgical disc replacements common today."

Maaike de Jong

PDEng, Medical Application Engineer at Scinvivo

"When we first came to NLC, we had just developed a very promising product for improving bladder cancer diagnosis. With the expertise and guidance of NLC this product was turned into a promising business. NLC advised on estimating the risks, validating the medical need, and defining the path towards the first saleable product."

Prof. Dr. Peter Desain

Inventor, origin: Radboud University

“ALS can lead to partial or complete paralysis, where the patient is left unable to ommunicate. MindAffect’s brain computer interface provides a way for patients to control applications by using their brain signals, giving them back a piece of their independence.”

Rob de Ree

Former CEO Dezima Pharma

"From my experience with healthtech startups I see that there is a need for parties such as NLC. What's more, NLC has a talented and balanced team."

David Robbert Koolbergen

MD, PhD Congenital Cardiac surgeon

“As a physician, I lack the knowledge and expertise to start a business and do not have time to get more education on this topic. NLC does have this expertise, and can therefore cover the new business information for me, so I can still focus on my clinical work”

Eric Gerritsen

Secretary General of the Ministry of Health, Welfare and Sport

"It is fantastic that medical specialists belonging to an association can stimulate medical innovation in the Netherlands, together with NLC"

Joris Jaspers

Associate professor at UMC Utrecht and CTO at Lapara Surgical BV

"As a researcher and product innovator, I don't have the knowledge or expertise to translate a research prototype into business. NLC saw the business opportunity and has the expertise and network to bring the MIA to the clinic. NLC built the Lapara team, combining the complementary expertise of its members, in which I now participate. This way I can focus on my expertise and strengths, while learning a lot from my colleagues, both at Lapara Surgical and at NLC."

Rocco van den Berg

Innovation Lead at Philips Healthworks

"NLC convinces and stimulates the innovator to start-up a company. NLC will provide you the best people to make the startup a succes. This is very interesting for Philips, this is the very critical first step."

Prof. Dr. Edgar Dahl

Inventor, origin: Aachen University Hospital

“SNiPER’s liquid biopsy test allows for the early detection of breast cancer with improved sensitivity and specificity compared to mammography. By avoiding the discomforts of mammography, SNiPER can also increase early screening compliance, and reduce costs.”

Roel Melsert

Director Sanquinnovate

"Through our cooperation with NLC, the conversion of promising SanQuin research ideas into succesful and market-oriented product development will be accelerated."

W. Bemelman, MD

Surgeon at AMC

"As an surgeon I have many new ideas that aren't always used, but thanks to NLC I'm now operating on patients with my ons innovation. Isn't that great?"

BART NELISSEN

Business Developer at TU/e Innovation Lab

“We are particularly impressed with the structured approach of NLC to quickly evaluate the commercial potential of new medical inventions and the caliber of potential CEOs that NLC is able to recruit for our joint spin-off cases”

Hendrik Verschuur

ENT Specialist, MCH

"Contributing from my field of knowledge to innovative solutions during the NLC formation phase really compliments my work as an ENT specialist."